Company Profile

THYROCARE TECHNOLOGIES LTD.

NSE : THYROCAREBSE : 539871ISIN CODE : INE594H01019Industry : Hospital & Healthcare ServicesHouse : MNC
BSE469.055.05 (+1.09 % )
PREV CLOSE (Rs.) 464.00
OPEN PRICE (Rs.) 471.80
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 469.05 (1 )
VOLUME 2132
TODAY'S LOW / HIGH (Rs.)465.35 485.30
52 WK LOW / HIGH (Rs.)406.65 697
NSE469.00 4.4 (+0.95 % )
PREV CLOSE(Rs.) 464.60
OPEN PRICE (Rs.) 464.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 469.00 (25 )
VOLUME 35773
TODAY'S LOW / HIGH(Rs.) 460.00 484.95
52 WK LOW / HIGH (Rs.)407.15 694.8

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 4.26
TTM EPS (Rs.) 18.93
P/E Ratio 24.78
Book Value (Rs.) 91.29
Face Value (Rs.) 10
MCap (Rs. in Mn) 24765.19
Price/Earning (TTM) 21.47
Price/Sales (TTM) 6.49
Price/Book (MRQ) 5.14
PAT Margin (%) 25.75
ROCE (%) 32.41
Incorporation Year : 2000

Management Info :

A Velumani - Chairman A Velumani - Managing Director

Registered Office :

Address : D - 37/1, Ttc Industrial Area,M I D C,Turbhe,
Navi Mumbai,
Maharashtra-400703

Phone : 022 2762 2762

Website : www.thyrocare.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
12Aug08-12-2019$Thyrocare Technologies informs about quarterly results presentation Thyrocare Technologies infor

Thyrocare Technologies has informed about copy of Presentation on Quarterly Results of the company for the quarter ended 30-06-2019. This is only uploaded in its website, and has not been distributed or advertised in newspapers or otherwise publicised.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Technologies has informed about copy of Presentation..
24Jun06-24-2019$Thyrocare Technologies informs about analyst meetings Thyrocare Technologies infor

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed about forthcoming Analyst Meetings to be held at the Corporate Office of the Company. Meeting with the representative(s) of Securities Investment Management Pvt. Ltd., will be held at 3.30 PM on Wednesday, June 26, 2019; and meeting with the representative(s) of HDFC Securities Limited, will be held at 4.30 PM on Wednesday, June 26, 2019. These meetings are subject to any last minute changes.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disc..
14Jun06-14-2019$Appointment of Director Appointment of Director
inter alia, approved the following: Please refer to our letter dated 20-05-2019, intimating that at the Board Meeting on 18-05- 2019, when Auditors pointed out impairment of investment in Nueclear Healthcare Limited (NHL), wholly owned subsidiary, Dr.A.Velumani, Chairman, MD & CEO offered to buy Company's entire shareholding in NHL at the current investment value of Rs. 194.67 crores to ensure that there is no loss to the public shareholders. This offer was discussed today by Audit Committee and Board. Both Audit Committee and Board have unanimously decided that Company has to determine whether it would be beneficial to hive off the subsidiary or retain it, and for this purpose, it would be advisable to obtain one more valuation report to ensure that the valuation of the subsidiary is correctly ascertained. The Committee decided to appoint a SEBI approved merchant banker to submit a valuation report in the shortest possible time and then take a decision.
inter alia, approved the following: Please refer to our letter..
23May05-23-2019$Thyrocare Technologies informs about conference call Thyrocare Technologies infor

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that the representative(s) of SAIF Partners would be having a Con-call with the company by 3.00 P.M. today (Thursday, May 23, 2019).

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disc..
22May05-22-2019$Cyient, Indiabulls Housing Finance and Infosys to see some action today Cyient, Indiabulls Housing F

Cyient has signed a partnership agreement with OneStrand Inc. to offer interactive technical publication solutions. This agreement combines Cyient’s global reach and long history in authoring, illustrating, designing, and converting technical publications with OneStrand’s world leading S1000D software and technical services.

Indiabulls Housing Finance has received approval for issuance of $350 million 6.375% payable semi-annually (6.29% nominal monthly) Senior Secured Notes due May 2022 under the updated $1,500 million Secured Euro Medium Term Note Programme of the Company.

Infosys Finacle, part of EdgeVerve Systems, a wholly owned subsidiary of Infosys, and Global Treasure Bank (GTB), successfully implemented the Finacle Core Banking solution at the Bank. GTB now leverages Finacle’s proven platform to power its retail and corporate operations across 163 branches across the country, engaging its customers with a truly digital banking experience and an enriched product and services portfolio.

UFO Moviez India has received approval for dissolution of UFO Lanka, a wholly owned subsidiary of the Company. As there are no operations in UFO Lanka, the Board of Directors of the Company have approved dissolution of UFO Lanka at its meeting held on May 21, 2019.

Alkali Metals has received an Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its Visakhapatnam Unit in Andhra Pradesh. The Visakhapatnam unit manufactures Active Pharmaceutical Ingredients (APIs) and other Chemical intermediates. The EIR from USFDA indicates closure of the inspection and that the Unit is in acceptable state of Compliance of Current Good Manufacturing Practice (CGMP).

Vodafone Idea has entered into partnership with Hyundai AutoEver India, a subsidiary of Hyundai Motor Group, for roll-out of connected car services. The tie-up will enable Hyundai cars, starting with its recently launched SUV Hyundai VENUE, to offer what it terms ‘advanced connected car functionality’. The partnership will see Hyundai deploy a connected solution in Indian market with integration of eSIMS with Voice, 3G/4G data, SMS, etc.

Thyrocare Technologies has received Letter of Acceptance (LoA) for the tender floated by Municipal Corporation of Greater Mumbai (MCGM) for outsourcing of laboratory investigative services ‘Aapli Chikitsa’. The acceptance letter, authorized to provide laboratory investigative services ‘Aapli Chikitsa’ over a period of 4 years from the commencement of operations, to the MCGM affiliated hospitals and clinics in western suburban zone and city zone of Mumbai.

Cyient has signed a partnership agreement with OneStrand Inc. t..
Financials More
Rs. in Millions
QTR Jun 19 ANNUAL 19
Net Profit301952.3
Gross Profit 429.6 1468.6
Operating Profit 473.71618
Net Sales 10053702.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Metropolis Health. (BSE)
 1032.45 (0.87%)
M.Cap ( in Cr)
5180.70
Aster DM Healthcare (BSE)
 122.55 (1.74%)
M.Cap ( in Cr)
6191.56
NG Industries (BSE)
 57.55 (0.17%)
M.Cap ( in Cr)
19.28
Indraprastha Medical (BSE)
 36.85 (0.14%)
M.Cap ( in Cr)
337.82
Invicta Meditek (BSE)
 4.30 (1.18%)
M.Cap ( in Cr)
3.10
Shareholding Pattern More
NON-INSTITUTION 8.98 %
PROMOTERS 65.95 %
MUTUAL FUNDS/UTI 13.84 %
FI/BANKS/INSURANCE 0.33 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes